Changeflow GovPing Healthcare FDA Class II Device Recall: GEM Premier 5000
Urgent Enforcement Amended Final

FDA Class II Device Recall: GEM Premier 5000

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has issued an ongoing Class II device recall for Instrumentation Laboratory's GEM Premier 5000 due to customer complaints of Process Control Solution Not Detected (PCSND) errors. This recall affects worldwide distribution, including the US.

What changed

The FDA has classified a recall of the GEM Premier 5000 device (Part No. 00055415005) as Class II, indicating that use of or exposure to a defective product may cause adverse health consequences that are temporary or medically reversible. The issue stems from confirmed customer complaints reporting an increased incidence of 'Process Control Solution Not Detected' (PCSND) errors during the warm-up phase of GEM PAKs (cartridges), leading to GEM PAK ejection and requiring re-insertion.

Manufacturers and distributors involved in the worldwide distribution of this device, including within the US, must ensure compliance with recall procedures. While the document does not specify immediate actions for end-users beyond the recall itself, affected parties should be aware of the potential for device malfunction and the need for prompt resolution by the manufacturer. The recall is ongoing, and further information may be available through the FDA's openFDA Enforcement API.

What to do next

  1. Review recall procedures for GEM Premier 5000 devices
  2. Monitor FDA communications regarding recall status

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1533-2026 · 20260318 · Ongoing

Product

GEM Premier 5000; Part No. 00055415005.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1533-2026

Who this affects

Applies to
Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Device Recalls
Threshold
Class II
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Product Safety Recall Management

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.